These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33917458)

  • 1. Inhibition of Liver Metastasis in Colorectal Cancer by Targeting IL-13/IL13Rα2 Binding Site with Specific Monoclonal Antibodies.
    Jaén M; Bartolomé RA; Aizpurua C; Martin-Regalado Á; Imbaud JI; Casal JI
    Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33917458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An IL13Rα2 peptide exhibits therapeutic activity against metastatic colorectal cancer.
    Bartolomé RA; Jaén M; Casal JI
    Br J Cancer; 2018 Oct; 119(8):940-949. PubMed ID: 30318506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal Antibodies Directed against Cadherin RGD Exhibit Therapeutic Activity against Melanoma and Colorectal Cancer Metastasis.
    Bartolomé RA; Aizpurua C; Jaén M; Torres S; Calviño E; Imbaud JI; Casal JI
    Clin Cancer Res; 2018 Jan; 24(2):433-444. PubMed ID: 28916526
    [No Abstract]   [Full Text] [Related]  

  • 4. Protein Tyrosine Phosphatase-1B Inhibition Disrupts IL13Rα2-Promoted Invasion and Metastasis in Cancer Cells.
    Bartolomé RA; Martín-Regalado Á; Jaén M; Zannikou M; Zhang P; de Los Ríos V; Balyasnikova IV; Casal JI
    Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32098194
    [No Abstract]   [Full Text] [Related]  

  • 5. IL13 Receptor α2 Signaling Requires a Scaffold Protein, FAM120A, to Activate the FAK and PI3K Pathways in Colon Cancer Metastasis.
    Bartolomé RA; García-Palmero I; Torres S; López-Lucendo M; Balyasnikova IV; Casal JI
    Cancer Res; 2015 Jun; 75(12):2434-44. PubMed ID: 25896327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel target anti-interleukin-13 receptor subunit alpha-2 monoclonal antibody inhibits tumor growth and metastasis in lung cancer.
    Raza G; Yunus FU; Mangukiya HB; Merugu SB; Mashausi DS; Zeling W; Negi H; Zhou B; Roy D; Wu Z; Li D
    Int Immunopharmacol; 2021 Jan; 90():107155. PubMed ID: 33243603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasis.
    Papageorgis P; Ozturk S; Lambert AW; Neophytou CM; Tzatsos A; Wong CK; Thiagalingam S; Constantinou AI
    Breast Cancer Res; 2015 Jul; 17(1):98. PubMed ID: 26208975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-13 receptor α2 is a negative prognostic factor in human lung cancer and stimulates lung cancer growth in mice.
    Xie M; Wu XJ; Zhang JJ; He CS
    Oncotarget; 2015 Oct; 6(32):32902-13. PubMed ID: 26418721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and immunotherapeutic implications for a novel antibody targeting interleukin (IL)-13 receptor α2.
    Balyasnikova IV; Wainwright DA; Solomaha E; Lee G; Han Y; Thaci B; Lesniak MS
    J Biol Chem; 2012 Aug; 287(36):30215-27. PubMed ID: 22778273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine induction of VCAM-1 but not IL13Rα2 on glioma cells: a tale of two antibodies.
    Mahadev V; Starr R; Wright SL; Martinez C; Jensen MC; Barish ME; Forman SJ; Brown CE
    PLoS One; 2014; 9(5):e95123. PubMed ID: 24787244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 13 receptor alpha 2 (IL13Rα2): Expression, signaling pathways and therapeutic applications in cancer.
    Jaén M; Martín-Regalado Á; Bartolomé RA; Robles J; Casal JI
    Biochim Biophys Acta Rev Cancer; 2022 Sep; 1877(5):188802. PubMed ID: 36152905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of the alpha2 chain of the interleukin-13 receptor in metastatic human prostate cancer ARCaPM cells.
    He H; Xu J; Nelson PS; Marshall FF; Chung LW; Zhau HE; He D; Wang R
    Prostate; 2010 Jun; 70(9):993-1001. PubMed ID: 20166133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activin A Signaling Regulates IL13Rα2 Expression to Promote Breast Cancer Metastasis.
    Kalli M; Mpekris F; Wong CK; Panagi M; Ozturk S; Thiagalingam S; Stylianopoulos T; Papageorgis P
    Front Oncol; 2019; 9():32. PubMed ID: 30805303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel single-chain antibody redirects adenovirus to IL13Rα2-expressing brain tumors.
    Kim JW; Young JS; Solomaha E; Kanojia D; Lesniak MS; Balyasnikova IV
    Sci Rep; 2015 Dec; 5():18133. PubMed ID: 26656559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LPS-induced TLR4 signaling in human colorectal cancer cells increases beta1 integrin-mediated cell adhesion and liver metastasis.
    Hsu RY; Chan CH; Spicer JD; Rousseau MC; Giannias B; Rousseau S; Ferri LE
    Cancer Res; 2011 Mar; 71(5):1989-98. PubMed ID: 21363926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.
    Ding C; Li L; Yang T; Fan X; Wu G
    BMC Cancer; 2016 Oct; 16(1):791. PubMed ID: 27729020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic Expression of IL15 Improves Antiglioma Activity of IL13Rα2-CAR T Cells but Results in Antigen Loss Variants.
    Krenciute G; Prinzing BL; Yi Z; Wu MF; Liu H; Dotti G; Balyasnikova IV; Gottschalk S
    Cancer Immunol Res; 2017 Jul; 5(7):571-581. PubMed ID: 28550091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein- and DNA-based active immunotherapy targeting interleukin-13 receptor alpha2.
    Mintz A; Gibo DM; Madhankumar AB; Cladel NM; Christensen ND; Debinski W
    Cancer Biother Radiopharm; 2008 Oct; 23(5):581-9. PubMed ID: 18976118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpressed ACP5 has prognostic value in colorectal cancer and promotes cell proliferation and tumorigenesis via FAK/PI3K/AKT signaling pathway.
    Bian ZQ; Luo Y; Guo F; Huang YZ; Zhong M; Cao H
    Am J Cancer Res; 2019; 9(1):22-35. PubMed ID: 30755809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting metastatic breast cancer with peptide epitopes derived from autocatalytic loop of Prss14/ST14 membrane serine protease and with monoclonal antibodies.
    Kim KY; Yoon M; Cho Y; Lee KH; Park S; Lee SR; Choi SY; Lee D; Yang C; Cho EH; Jeon SD; Kim SH; Kim C; Kim MG
    J Exp Clin Cancer Res; 2019 Aug; 38(1):363. PubMed ID: 31426843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.